PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

wtf is going on, page-124

  1. 1,061 Posts.
    lightbulb Created with Sketch. 532

    By end Jan there should be information on a Senate inquiry from a couple of HC posters which may overlap the issue of raising capital for mid caps in early expansion stage such as PAR, although its scope is directed towards financial technology and regulatory matters. The lead Senator is A.Bragg. ASIC is the appropriate regulator.
    If it looks relevant i will let you know.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.